Concepedia
4
Publications
68
Citations
H-Index
2013
Active since
Affiliations
Janssen (Germany)(Current)
Daniel Wirth is an author at Janssen (Germany).
Publications per year
2013–2020
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany
Daniel Wirth, R.N. Dass, Robert Hettle · BMC Health Services Research · 2017 · 25 citations · Full text
Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany
Inna Dabisch, Jürgen Dethling, Charalabos‐Markos Dintsios et al. · Health Economics Review · 2014 · 18 citations · Full text
Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany
Matthias Augustin, Daniel Wirth, Jörg Mahlich et al. · Journal of Dermatological Treatment · 2020 · 14 citations · Full text
Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
Jona T. Stahmeyer, Svenja Schauer, S. Rossol et al. · Journal of health economics and outcomes research · 2013 · 11 citations · Full text
Rows per page
1–4 of 4